Novel oncoprotein EPS8: a new target for anticancer therapy

By Li Yu-Hua   Xue Tong-Yuan   He Ying-Zhi   Du Jing-Wen  

Future Oncology, Vol. 9, Iss. 10, 2013-10 ,pp. : 1587-1594

Future Medicine

Access to resources Recommend Favorite

Endothelin Receptor Antagonists in Cancer Therapy

By Lalich Mihailo   McNeel Douglas   Wilding George   Liu Glenn  

Cancer Investigation, Vol. 25, Iss. 8, 2007-10 ,pp. : 785-794

Informa Healthcare

Access to resources Recommend Favorite

Activated vitronectin as a target for anticancer therapy with human antibodies

By Bloemendal Haiko   Boer Hetty   Koop Elianne   Dongen Alice   Goldschmeding Roel   Landman Wil   Logtenberg Ton   Gebbink Martijn   Voest Emile  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 9, 2004-09 ,pp. : 799-808

Springer Publishing Company

Access to resources Recommend Favorite

Tyrosyl-DNA Phosphodiesterase as a Target for Anticancer Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 4, 2008-05 ,pp. : 381-389

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Phosphatase 2A as a Potential Target for Anticancer Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 1, 2011-01 ,pp. : 38-46

Bentham Science Publishers

Access to resources Recommend Favorite